Selected research
Market Structure
Global Marine Biomedicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Marine Biomedicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Marine Biomedicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Marine Biomedicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Marine Biomedicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Marine Biomedicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Marine Biomedicine include Sams, Nofima, NEB, Marinova, Marine Biotech, GlycoMar, BiotechMarine and Aquapharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Marine Biomedicine market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Marine Biomedicine and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Marine Biomedicine revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Marine Biomedicine market size, projected growth trends, production technologies, key applications, and end-use industries.
Marine Biomedicine Segment by Company
Sams
Nofima
NEB
Marinova
Marine Biotech
GlycoMar
BiotechMarine
Aquapharm
Marine Biomedicine Segment by Type
Marine Animal Technolog
Marine Plant Technology
Marine Biomedicine Segment by Application
Drug
Health Care Products
Marine Biomedicine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Marine Biomedicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Marine Biomedicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Marine Biomedicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Marine Biomedicine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Marine Biomedicine industry.
Chapter 3: Detailed analysis of Marine Biomedicine companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Marine Biomedicinerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Marine Animal Technolog
- Marine Plant Technology
Applications
- Drug
- Health Care Products
Companies covered
- Sams
- Nofima
- NEB
- Marinova
- Marine Biotech
- GlycoMar
- BiotechMarine
- Aquapharm
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Marine Biomedicine Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Marine Animal Technolog
- 1.2.3 Marine Plant Technology
- 1.3 Market Analysis by Application
- 1.3.1 Global Marine Biomedicine Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Drug
- 1.3.3 Health Care Products
- 1.4 Global Market Growth Prospects
- 1.5 Global Marine Biomedicine Growth Trends by Region
- 1.5.1 Global Marine Biomedicine Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Marine Biomedicine Market Size by Region (2021-2026)
- 1.5.3 Marine Biomedicine Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Marine Biomedicine Market Dynamics
- 2.1 Marine Biomedicine Industry Trends
- 2.2 Marine Biomedicine Industry Drivers
- 2.3 Marine Biomedicine Industry Opportunities and Challenges
- 2.4 Marine Biomedicine Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Marine Biomedicine Revenue by Company (2021-2026)
- 3.2 Global Marine Biomedicine Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Marine Biomedicine Key Company Head office and Area Served
- 3.4 Global Marine Biomedicine Company, Product Type & Application
- 3.5 Global Marine Biomedicine Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Marine Biomedicine Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Marine Biomedicine Players Market Share by Revenue in 2025
- 3.6.3 2025 Marine Biomedicine Tier 1, Tier 2, and Tier 3
4 Marine Biomedicine Market by Type
- 4.1 Global Marine Biomedicine Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Marine Biomedicine Market Size by Type (2021-2032)
- 4.3 Global Marine Biomedicine Market Size Share by Type (2021-2032)
5 Marine Biomedicine Market by Application
- 5.1 Global Marine Biomedicine Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Marine Biomedicine Market Size by Application (2021-2032)
- 5.3 Global Marine Biomedicine Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Sams
- 6.1.1 Sams Company Information
- 6.1.2 Sams Business Overview
- 6.1.3 Sams Marine Biomedicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Sams Marine Biomedicine Product Portfolio
- 6.1.5 Sams Recent Developments
- 6.2 Nofima
- 6.2.1 Nofima Company Information
- 6.2.2 Nofima Business Overview
- 6.2.3 Nofima Marine Biomedicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Nofima Marine Biomedicine Product Portfolio
- 6.2.5 Nofima Recent Developments
- 6.3 NEB
- 6.3.1 NEB Company Information
- 6.3.2 NEB Business Overview
- 6.3.3 NEB Marine Biomedicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 NEB Marine Biomedicine Product Portfolio
- 6.3.5 NEB Recent Developments
- 6.4 Marinova
- 6.4.1 Marinova Company Information
- 6.4.2 Marinova Business Overview
- 6.4.3 Marinova Marine Biomedicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Marinova Marine Biomedicine Product Portfolio
- 6.4.5 Marinova Recent Developments
- 6.5 Marine Biotech
- 6.5.1 Marine Biotech Company Information
- 6.5.2 Marine Biotech Business Overview
- 6.5.3 Marine Biotech Marine Biomedicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Marine Biotech Marine Biomedicine Product Portfolio
- 6.5.5 Marine Biotech Recent Developments
- 6.6 GlycoMar
- 6.6.1 GlycoMar Company Information
- 6.6.2 GlycoMar Business Overview
- 6.6.3 GlycoMar Marine Biomedicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 GlycoMar Marine Biomedicine Product Portfolio
- 6.6.5 GlycoMar Recent Developments
- 6.7 BiotechMarine
- 6.7.1 BiotechMarine Company Information
- 6.7.2 BiotechMarine Business Overview
- 6.7.3 BiotechMarine Marine Biomedicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 BiotechMarine Marine Biomedicine Product Portfolio
- 6.7.5 BiotechMarine Recent Developments
- 6.8 Aquapharm
- 6.8.1 Aquapharm Company Information
- 6.8.2 Aquapharm Business Overview
- 6.8.3 Aquapharm Marine Biomedicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Aquapharm Marine Biomedicine Product Portfolio
- 6.8.5 Aquapharm Recent Developments
7 North America
- 7.1 North America Marine Biomedicine Market Size (2021-2032)
- 7.2 North America Marine Biomedicine Market Size by Type
- 7.2.1 North America Marine Biomedicine Market Size by Type (2021-2026)
- 7.2.2 North America Marine Biomedicine Market Size by Type (2027-2032)
- 7.2.3 North America Marine Biomedicine Market Share by Type (2021-2032)
- 7.3 North America Marine Biomedicine Market Size by Application
- 7.3.1 North America Marine Biomedicine Market Size by Application (2021-2026)
- 7.3.2 North America Marine Biomedicine Market Size by Application (2027-2032)
- 7.3.3 North America Marine Biomedicine Market Share by Application (2021-2032)
- 7.4 North America Marine Biomedicine Market Size by Country
- 7.4.1 North America Marine Biomedicine Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Marine Biomedicine Market Size by Country (2021-2026)
- 7.4.3 North America Marine Biomedicine Market Size by Country (2027-2032)
- 7.4.4 North America Marine Biomedicine Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Marine Biomedicine Market Size (2021-2032)
- 8.2 Europe Marine Biomedicine Market Size by Type
- 8.2.1 Europe Marine Biomedicine Market Size by Type (2021-2026)
- 8.2.2 Europe Marine Biomedicine Market Size by Type (2027-2032)
- 8.2.3 Europe Marine Biomedicine Market Share by Type (2021-2032)
- 8.3 Europe Marine Biomedicine Market Size by Application
- 8.3.1 Europe Marine Biomedicine Market Size by Application (2021-2026)
- 8.3.2 Europe Marine Biomedicine Market Size by Application (2027-2032)
- 8.3.3 Europe Marine Biomedicine Market Share by Application (2021-2032)
- 8.4 Europe Marine Biomedicine Market Size by Country
- 8.4.1 Europe Marine Biomedicine Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Marine Biomedicine Market Size by Country (2021-2026)
- 8.4.3 Europe Marine Biomedicine Market Size by Country (2027-2032)
- 8.4.4 Europe Marine Biomedicine Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Marine Biomedicine Market Size (2021-2032)
- 9.2 China Marine Biomedicine Market Size by Type
- 9.2.1 China Marine Biomedicine Market Size by Type (2021-2026)
- 9.2.2 China Marine Biomedicine Market Size by Type (2027-2032)
- 9.2.3 China Marine Biomedicine Market Share by Type (2021-2032)
- 9.3 China Marine Biomedicine Market Size by Application
- 9.3.1 China Marine Biomedicine Market Size by Application (2021-2026)
- 9.3.2 China Marine Biomedicine Market Size by Application (2027-2032)
- 9.3.3 China Marine Biomedicine Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Marine Biomedicine Market Size (2021-2032)
- 10.2 Asia Marine Biomedicine Market Size by Type
- 10.2.1 Asia Marine Biomedicine Market Size by Type (2021-2026)
- 10.2.2 Asia Marine Biomedicine Market Size by Type (2027-2032)
- 10.2.3 Asia Marine Biomedicine Market Share by Type (2021-2032)
- 10.3 Asia Marine Biomedicine Market Size by Application
- 10.3.1 Asia Marine Biomedicine Market Size by Application (2021-2026)
- 10.3.2 Asia Marine Biomedicine Market Size by Application (2027-2032)
- 10.3.3 Asia Marine Biomedicine Market Share by Application (2021-2032)
- 10.4 Asia Marine Biomedicine Market Size by Country
- 10.4.1 Asia Marine Biomedicine Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Marine Biomedicine Market Size by Country (2021-2026)
- 10.4.3 Asia Marine Biomedicine Market Size by Country (2027-2032)
- 10.4.4 Asia Marine Biomedicine Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Marine Biomedicine Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Marine Biomedicine Market Size by Type
- 11.2.1 South America, Middle East & Africa Marine Biomedicine Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Marine Biomedicine Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Marine Biomedicine Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Marine Biomedicine Market Size by Application
- 11.3.1 South America, Middle East & Africa Marine Biomedicine Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Marine Biomedicine Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Marine Biomedicine Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Marine Biomedicine Market Size by Country
- 11.4.1 South America, Middle East & Africa Marine Biomedicine Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Marine Biomedicine Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Marine Biomedicine Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Marine Biomedicine Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst